Blood levels of erythropoietin in congestive heart failure and correlation with clinical, hemodynamic, and hormonal profiles
- 1 September 1994
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 74 (5), 468-473
- https://doi.org/10.1016/0002-9149(94)90905-9
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Direct vasopressor effect of recombinant human erythropoietin on renal resistance vesselsKidney International, 1991
- Hemodynamic changes by recombinant erythropoietin therapy in hemodialyzed patients.Hypertension, 1990
- Erythropoietin in cyanotic heart diseaseAmerican Heart Journal, 1988
- Serum erythropoietin levels in patients with congenital heart diseaseThe Journal of Pediatrics, 1987
- Atrial Natriuretic Peptide and Atrial Pressure in Patients with Congestive Heart FailureNew England Journal of Medicine, 1986
- Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale.Circulation, 1981
- Acute regional circulatory and renal hemodynamic effects of converting-enzyme inhibition in patients with congestive heart failure.Circulation, 1981
- Blood volume changes in cyanotic congenital heart diseaseThe American Journal of Cardiology, 1971
- Hormones and the Pathogenesis of Congestive Heart Failure:Vasopressin, Aldosterone, and Angiotensin IICirculation, 1962
- Role of the Kidney in the Pathogenesis of Congestive Heart FailureCirculation, 1959